Enhanced anti-tuberculosis immunity by a TAT-Ag85B protein vaccine in a murine tuberculosis model

References

• World Health Organization. Global tuberculosis control, chapter 2;2012. p. 8–28.
   Google Scholar
• Ritz N, Strach M, Yau C, Dutta B, Tebruegge M, Connell TG, et al. A comparative analysis of polyfunctional T cells and secreted cytokines induced by Bacille Calmette-Guérin immunisation in children and adults. PLoS ONE 2012;7:e37535.10.1371/journal.pone.0037535
   Google Scholar
• Park JS, Kim HS, Park HM, Kim CH, Kim TG. Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model. Vaccine 2011;29(47):8642–8.10.1016/j.vaccine.2011.09.052
   PubMed Web of Science ®Google Scholar
• Fittipaldi A, Giacca M. Transcellular protein transduction using the Tat protein of HIV-1. Adv Drug Deliv Rev. 2005;57(4):597–608.10.1016/j.addr.2004.10.011
   PubMed Web of Science ®Google Scholar
• Wadia JS, Dowdy SF. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv Drug Deliv Rev. 2005;57(4):579–96.10.1016/j.addr.2004.10.005
   PubMed Web of Science ®Google Scholar
• Wu Y, Ren C, Gao Y, Hou B, Chen T, Zhang C. A novel method for promoting heterologous protein expression in Escherichia coli by fusion with the HIV-1 TAT core domain. Amino Acids 2010;39(3):811–20.10.1007/s00726-010-0534-2
   PubMed Web of Science ®Google Scholar
• Park JS, Kim HS, Park HM, Kim CH, Kim TG. Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model. Vaccine 2011;29(47):8642–8.10.1016/j.vaccine.2011.09.052
   PubMed Web of Science ®Google Scholar
• Fanales-Belasio E, Moretti S, Fiorelli V, Tripiciano A, Pavone Cossut MR, Scoglio A, et al. HIV-1 tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection. J Immunol. 2009;182(5):2888–97.10.4049/jimmunol.0711406
   PubMed Web of Science ®Google Scholar
• Dong H, Jing W, Yabo Y, Xiaokang Y, Wan W, Min M, et al. Establishment of rat model of silicotuberculosis and its pathological characteristic. Pathog Glob Health 2014;108(7):312–6.10.1179/2047773214Y.0000000157
   PubMed Web of Science ®Google Scholar
• Doherty TM, Olsen AW, Weischenfeldt J, Huygen K, D’Souza S, Kondratieva TK, et al. Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis. J Infect Dis. 2004;190(12):2146–53.10.1086/jid.2004.190.issue-12
   PubMed Web of Science ®Google Scholar
• Wang C, Fu R, Chen Z, Tan K, Chen L, Teng X, et al. Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B. Clin Dev Immunol. 2012;2012:563838.
   PubMedGoogle Scholar
• Hu D, Wu J, Zhang R, Chen L. T-bet acts as a powerful adjuvant in Ag85B DNA-based vaccination against tuberculosis. Mol Med Rep. 2012;6(1):139–44.
   PubMed Web of Science ®Google Scholar
• Kanhere A, Hertweck A, Bhatia U, Gökmen MR, Perucha E, Jackson I, et al. T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements. Nat Commun. 2012;3:1268.10.1038/ncomms2260
   PubMed Web of Science ®Google Scholar
• Józefowski S, Sobota A, Kwiatkowska K. How Mycobacterium tuberculosis subverts host immune responses. BioEssays 2008;30(10):943–54.10.1002/bies.v30:10
   PubMed Web of Science ®Google Scholar
• Wu J, Hu D, Du JW, Tao XR, Qi XL, Zhang RB. Th1 immunity is not required for the effect of lipopolysaccharide exposure on modifying asthmatic responses of mice before sensitization. Chin Med J (Engl). 2010;123:1047–51.
   PubMed Web of Science ®Google Scholar
• Chen X, Lai J, Pan Q, Tang Z, Yu Y, Zang G. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice. Vaccine 2010;28(23):3913–9.10.1016/j.vaccine.2010.03.070
   PubMed Web of Science ®Google Scholar
• Yang M, Wang S, Wang S, Ma J, Xu X, Mao C, et al. Tat-mediated intracellular delivery of T-bet protein into THP-1 cells can induce Th1-Type response. Immunol Invest. 2008;37(2):97–111.10.1080/08820130701690725
   PubMed Web of Science ®Google Scholar
• Chen X, Yu Y, Pan Q, Tang Z, Han J, Zang G. Enhancement of cytotoxic T lymphocyte activity by dendritic cells loaded with Tat-protein transduction domain-fused hepatitis B virus core antigen. Acta Biochim Biophys Sin (Shanghai). 2008;40(12):996–1004.10.1111/abbs.2008.40.issue-12
   PubMed Web of Science ®Google Scholar
• Kanhere A, Hertweck A, Bhatia U, Gökmen MR, Perucha E, Jackson I, et al. T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements. Nat Commun. 2012;3:1268.10.1038/ncomms2260
   PubMed Web of Science ®Google Scholar
• Lipscomb MW, Chen L, Taylor JL, Goldbach C, Watkins SC, Kalinski P, et al. Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro. J Immunol. 2009;183(11):7250–8.10.4049/jimmunol.0901477
   PubMed Web of Science ®Google Scholar
• Green AM, DiFazio R, Flynn JL. IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. J Immunol. 2013;190(1):270–7.10.4049/jimmunol.1200061
   PubMed Web of Science ®Google Scholar
• Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC. Tuberculosis vaccine research: the impact of immunology. Curr Opin Immunol. 2009;21(3):331–8.10.1016/j.coi.2009.05.017
   PubMed Web of Science ®Google Scholar
• Dheda K, Schwander SK, Zhu B, van Zyl-Smit RN, Zhang Y. The immunology of tuberculosis: from bench to bedside. Respirology 2010;15(3):433–50.10.1111/res.2010.15.issue-3
   PubMed Web of Science ®Google Scholar